1. Voigt J, Krause C, Rohwäder E, Saschenbrecker S, Hahn M, Danckwardt M, et al. Automated indirect immunofluorescence evaluation of antinuclear autoantibodies on HEp-2 cells. Clin Dev Immunol. 2012; 2012:651058. PMID:
23251220.
2. Meroni PL, Schur PH. ANA screening: an old test with new recommendations. Ann Rheum Dis. 2010; 69:1420–1422. PMID:
20511607.
3. Roggenbuck D, Hiemann R, Bogdanos D, Reinhold D, Conrad K. Standardization of automated interpretation of immunofluorescence tests. Clin Chim Acta. 2013; 421:168–169. PMID:
23537734.
4. Bizzaro N, Antico A, Platzgummer S, Tonutti E, Bassetti D, Pesente F, et al. Automated antinuclear immunofluorescence antibody screening: a comparative study of six computer-aided diagnostic systems. Autoimmun Rev. 2014; 13:292–298. PMID:
24220268.
5. Schouwers S, Bonnet M, Verschueren P, Westhovens R, Blockmans D, Marien G, et al. Value-added reporting of antinuclear antibody testing by automated indirect immunofluorescence analysis. Clin Chem Lab Med. 2014; 52:547–551. PMID:
24225130.
6. Krause C, Ens K, Fechner K, Voigt J, Fraune J, Rohwäder E, et al. EUROPattern Suite technology for computer-aided immunofluorescence microscopy in autoantibody diagnostics. Lupus. 2015; 24:516–529. PMID:
25801895.
7. Gerlach S, Affeldt K, Pototzki L, Krause C, Voigt J, Fraune J, et al. Automated Evaluation of Crithidia luciliae Based Indirect Immunofluorescence Tests: A Novel Application of the EUROPattern-Suite Technology. J Immunol Res. 2015; 2015:742402. PMID:
26581239.
8. Szalat R, Ghillani-Dalbin P, Jallouli M, Amoura Z, Musset L, Cacoub P, et al. Anti-NuMA1 and anti-NuMA2 (anti-HsEg5) antibodies: Clinical and immunological features: A propos of 40 new cases and review of the literature. Autoimmun Rev. 2010; 9:652–656. PMID:
20457279.
9. Kim JM, Ihm CH, Sin DH, Ihm MK, Sim SC. Detection of anti-ENA and anti-dsDNA antibodies using line immunoassay in systemic autoimmune diseases. Korean J Lab Med. 2008; 28:353–361. PMID:
18971616.
10. Rothberger H, Lee TK, Wise C. Disease distributions in patients with multiple patterns of nuclear staining detected by FANA (immunofluorescent antinuclear antibody) tests. Clin Exp Rheumatol. 1986; 4:201–207. PMID:
3533338.
11. Meroni PL, Bizzaro N, Cavazzana I, Borghi MO, Tincani A. Automated tests of ANA immunofluorescence as throughput autoantibody detection technology: strengths and limitations. BMC Med. 2014; 12:38. PMID:
24589329.
12. Ganapathy V, Casiano CA. Autoimmunity to the nuclear autoantigen DFS70 (LEDGF): what exactly are the autoantibodies trying to tell us? Arthritis Rheum. 2004; 50:684–688. PMID:
15022305.
13. Mahler M, Hanly JG, Fritzler MJ. Importance of the dense fine speckled pattern on HEp-2 cells and anti-DFS70 antibodies for the diagnosis of systemic autoimmune diseases. Autoimmun Rev. 2012; 11:642–645. PMID:
22100330.
14. Mahler M, Fritzler MJ. The clinical significance of the dense fine speckled immunofluorescence pattern on HEp-2 cells for the diagnosis of systemic autoimmune diseases. Clin Dev Immunol. 2012; 2012:494356. PMID:
23304189.
15. Chan EK, Damoiseaux J, Carballo OG, Conrad K, de Melo Cruvinel W, Francescantonio PL, et al. Report of the First International Consensus on Standardized Nomenclature of Antinuclear Antibody HEp-2 Cell Patterns 2014-2015. Front Immunol. 2015; 6:412. PMID:
26347739.
16. Damoiseaux J, von Mühlen CA, Garcia-De La Torre I, Carballo OG, de Melo Cruvinel W, Francescantonio PL, et al. International consensus on ANA patterns (ICAP): the bumpy road towards a consensus on reporting ANA results. Auto Immun Highlights. 2016; 7:1. PMID:
26831867.
17. Mulliez SM, Maenhout TM, Bonroy C. Impact of the routine implementation of automated indirect immunofluorescence antinuclear antibody analysis: 1 year of experience. Clin Chem Lab Med. 2016; 54:e183–e186. PMID:
26562038.
18. Wiliem A, Hobson P, Minchin RF, Lovell BC. A bag of cells approach for antinuclear antibodies HEp-2 image classification. Cytometry A. 2015; 87:549–557. PMID:
25492545.